《通货膨胀削减法》对罕见病药物开发的影响

尽管新法为许多患者带来了福音，但它已经对孤儿病患者的新药研发产生了影响。Not only are drugs that could treat more than one disease being disincentivized, small molecule medicines, which play an important role in treating neurological disorders, cancers, and other diseases, may also be disadvantaged by the law.